Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

SHE/301060 stock hub

SHE/301060 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301060is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301060

In the news

Latest news · SHE/301060

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E295.5

P25 23.5P50 41.3P75 83.2

ROE1.8

P25 -0.9P50 4.1P75 8.8

ROIC-4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301060 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

CNY

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,365
Employees Change	-122%
Employees Change Percent	-8.2
Enterprise value	CNY 3.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	CNE100004RG8
Last refreshed	2026-05-10
Market cap	CNY 4.3B
Price	CNY 10.91
Price currency	CNY
Rev Per Employee	1,014,145.74x
Sector	Healthcare
Sic	5047
Symbol	she/301060
Website	https://www.labway.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.33%
EV Earnings	263.64x
EV/EBIT	79.1x
EV/EBITDA	32.39x
EV/FCF	11.78x
EV/Sales	2.71x
FCF yield	7.33%
P/B ratio	2.58x
P/E ratio	295.47x
P/S ratio	3.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.43%
EBITDA Margin	8.38%
FCF margin	23.04%
Gross margin	25.68%
Gross Profit	CNY 355.5M
Gross Profit Growth	-9.81%
Gross Profit Growth Q	-25.24%
Gross Profit Growth3 Y	-42.01%
Gross Profit Growth5 Y	-2.57%
Net Income	CNY 14.2M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	4.59%
Profit Margin	1.03%
Profit Per Employee	CNY 10,438
ROA	1.2
Roa5y	5.93
ROCE	2.66
ROE	1.8
Roe5y	8.44
ROIC	-3.96
Roic5y	14.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	20.86%
Cagr3y	-14.96%
EPS Growth Quarters	3
EPS Growth Years	2
FCF Growth	50.59%
FCF Growth Q	-66%
FCF Growth5 Y	11.27%
OCF Growth	24.29%
OCF Growth Q	-60.3%
OCF Growth3 Y	47.27%
OCF Growth5 Y	9.88%
Revenue Growth	-16.88x
Revenue Growth Q	-18.05x
Revenue Growth Years	0x
Revenue Growth3 Y	-29.88x
Revenue Growth5 Y	3.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.56
Assets	CNY 2.3B
Cash	CNY 846.1M
Current Assets	CNY 1.8B
Current Liabilities	CNY 531.2M
Debt	CNY 158.1M
Debt EBITDA	CNY 1.36
Debt Equity	CNY 0.09
Debt FCF	CNY 0.5
Equity	CNY 1.7B
Liabilities	CNY 666.3M
Long Term Assets	CNY 596.6M
Long Term Liabilities	CNY 135.2M
Net Cash	CNY 688M
Net Cash By Market Cap	CNY 15.82
Net Cash Growth	6.02%
Net Debt EBITDA	CNY -5.93
Net Debt Equity	CNY -0.41
Net Debt FCF	CNY -2.16
Tangible Book Value	CNY 1.6B
Tangible Book Value Per Share	CNY 3.79
WACC	7.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.26
Inventory Turnover	3.16
Net Working Capital	CNY 483.6M
Quick ratio	2.71
Working Capital	CNY 1.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.18%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.2
Dividend Years	1
Dividend Yield	1.83%
Last Dividend	CNY 0.2
Payout Ratio	604.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	20.85%
200-day SMA	10.25
3Y total return	-38.5%
50-day SMA	10.18
50-day SMA vs 200-day SMA	50under200
All Time High	61.2
All Time High Change	-82.17%
All Time High Date	2022-03-16
All Time Low	7.34
All Time Low Change	48.64%
All Time Low Date	2024-02-06
ATR	0.36
Beta	0.56
Beta1y	0.55
Beta2y	1.1
Ch YTD	17.95
High	11.03
High52	14.55
High52 Date	2026-01-14
High52ch	-25.02%
Low	10.43
Low52	8.74
Low52 Date	2025-10-13
Low52ch	24.83%
Ma50ch	7.18%
Price vs 200-day SMA	6.47%
RSI	65.16
RSI Monthly	50.16
RSI Weekly	55.91
Sharpe ratio	0.65x
Sortino ratio	1.3
Total Return	7.01%
Tr YTD	17.95
Tr1m	9.65%
Tr1w	4.2%
Tr3m	-3.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 47.5M
Operating Income Growth	-0.91
Operating Income Growth Q	-86.83
Operating Income Growth3 Y	-69.78
Operating Income Growth5 Y	-28.5
Operating margin	3.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	160,354,812%
Net Borrowing	-85,800,000
Shares Insiders	15.05%
Shares Institutions	0.48%
Shares Out	398,520,900
Shares Qo Q	-9.93%
Shares Yo Y	-5.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 318.9M
Average Volume	8,079,076.4x
Bv Per Share	3.87
CAPEX	CNY -50.4M
Ch1m	9.65
Ch1w	4.2
Ch1y	18.33
Ch3m	-3.79
Ch3y	-40.87
Ch6m	10.2
Change	2.35%
Change From Open	1.02
Close	10.66
Days Gap	1.31
Depreciation Amortization	66,718,380
Dollar Volume	162,466,810.5
Earnings Date	2026-04-29
EBIT	CNY 47.5M
EBITDA	CNY 116M
EPS	CNY 0.04
F Score	6
FCF	CNY 318.9M
FCF EV Yield	8.49x
FCF Per Share	CNY 0.8
Financing CF	-268,202,187
Fiscal Year End	December
Founded	1,993
Goodwill	7,664,887
Graham Number	1.79225
Graham Upside	-83.57
Income Tax	CNY 32.1M
Investing CF	1,197,015
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Ma150	10.22
Ma150ch	6.77%
Ma20	9.96
Ma20ch	9.53%
Net CF	102,316,168
Next Earnings Date	2026-08-26
Open	10.8
P FCF Ratio	13.63
P OCF Ratio	11.77
Payment Date	2025-06-09
Position In Range	80
Ppne	434,040,687
Price Date	2026-05-08
Price EBITDA	CNY 37.49
Ptbv Ratio	2.8
Relative Volume	1.9x
Revenue	1,384,308,931x
Tax By Revenue	2.32x
Tax Rate	50.52%
Tr6m	10.2%
Volume	14,891,550

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301060 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.20 annual per share

Payout ratio

+604.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+7.0%

Dividend yield + buyback yield combined

Performance

SHE/301060 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301060?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+15.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-5.2%

Negative means the company is buying back shares.

Technical

SHE/301060 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.2

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301060

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301060 stock rating?

she/301060 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301060 analysis?

The full report lives at /stocks/she/301060/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301060?

The latest report frames she/301060 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301060 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.